# Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging

> **NCT02807779** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 33 (actual)

## Conditions studied

- Peripheral Artery Disease
- Vascular Disease
- Critical Limb Ischemia

## Interventions

- **DRUG:** Dexamethasone infusion
- **DEVICE:** Drug coated balloon
- **DEVICE:** Plain balloon angioplasty

## Key facts

- **NCT ID:** NCT02807779
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-10
- **Primary completion:** 2020-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2025-07-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02807779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02807779, "Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02807779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*